Applicant, as named in the Orange Book

Ibsa

Next listed expiry: Vybrique on 16 Dec 2033. 3 products with live protection, 1 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Vybrique NDA 210858 · 4 strengths sildenafil citrate	sildenafil citrate	16 Dec 2033 patent	patent
Tirosint NDA 021924 · 15 strengths levothyroxine sodium	levothyroxine sodium	26 Sep 2044 patent	patent
Tirosint-Sol NDA 206977 · 15 strengths levothyroxine sodium	levothyroxine sodium	26 Sep 2044 patent	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (1)

Drug	Ingredient	Earliest generic entry	Basis
Flector NDA 021234 diclofenac epolamine	diclofenac epolamine	open now no listed protection	no listed protection